Caption Management, LLC Coherus Bio Sciences, Inc. Put Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $227,600 - $402,800	40,000 New	40,000 $316,000
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $380,400 - $533,700	-30,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $388,500 - $462,300	30,000 New	30,000 $414,000
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $522,300 - $596,700	-30,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $432,900 - $574,800	30,000 New	30,000 $536,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.